Evidence map›Paper›PMID 33868785›Full record

ArticleMolecular therapy. Nucleic acids2021

Serum lncRNAs in early pregnancy as potential biomarkers for the prediction of pregnancy-induced hypertension, including preeclampsia.

Chenguang Dai, Chenyang Zhao, Minglu Xu, Xinshuang Sui, Li Sun, Yang Liu, Mengqi Su, Hongling Wang, Yue Yuan, Song Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. The Role of Angiogenetic Factors in Preeclampsia.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. [Research progress of iron metabolism and ferroptosis in myeloid neoplasms].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Chenguang DaiDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Chenyang ZhaoDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Minglu XuDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Xinshuang SuiDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Li SunDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Yang LiuDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Mengqi SuDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Hongling WangDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Yue YuanDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Song ZhangDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Jing ShiDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Jingxia SunDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Yue LiDepartment of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long noncoding RNAs (lncRNAs) are key mediators of biological regulation with diagnostic value as disease biomarkers. We explored serum lncRNA levels in early pregnancy as potential biomarkers of pregnancy-induced hypertension (PIH), including gestational hypertension (GH) and preeclampsia (PE). We performed a two-phase nested case-control study in pregnant women before 20 weeks' gestation (before clinical diagnosis). The screening phase assessed lncRNA expression profiles with a human lncRNA microarray in 5 pairs of serum samples (5 PE patients and 5 matched controls). The second phase validated levels of 8 candidate lncRNAs selected via the random walk method by quantitative real-time polymerase chain reaction (qRT-PCR). Serum levels of the 8 lncRNAs were markedly increased in women with PIH compared with matched normotensive pregnant (NP) women (p < 0.001), consistent with the microarray results. In addition, 7 candidate lncRNAs were correlated with PIH severity. Logistic regression analysis revealed that serum levels of ENST00000527727 (odds ratio [OR], 1.113; 95% confidence interval [CI], 1.024-1.209; p = 0.0113) and ENST00000415029 (OR, 1.126; 95% CI, 1.000-1.267; p = 0.0496) were associated with adverse pregnancy outcomes, such as fetal growth restriction (FGR) and placenta accreta of PIH. Nine pathways associated with the candidate lncRNAs had confirmed associations with PIH.

Indexed as

biomarkergestational hypertensionlncRNApreeclampsiapregnancy-induced hypertension

Identifiers

PMID33868785
PMCPMC8042241
OpenAlexW3138710894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.